📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis. (2022)

First Author: Newsome SJ

Attributed to: Development and practical application of landmarking in studies of time-varying exposures and survival funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/aje/kwab263

PubMed Identifier: 34753177

Publication URI: http://europepmc.org/abstract/MED/34753177

Type: Journal Article/Review

Volume: 191

Parent Publication: American journal of epidemiology

Issue: 3

ISSN: 0002-9262